Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | https://doi.org/10.1186/s13046-020-01805-6 |
Summary: | An amendment to this paper has been published and can be accessed via the original article. |
---|---|
ISSN: | 1756-9966 |